Join the 'Dystonia' group to help and get support from people like you.
FDA Allows Marketing of First Direct-to-Consumer Tests that Provide Genetic Risk Information for Certain Conditions
Posted 7 Apr 2017 by Drugs.com
April 6, 2017 – The U.S. Food and Drug Administration today allowed marketing of 23andMe Personal Genome Service Genetic Health Risk (GHR) tests for 10 diseases or conditions. These are the first direct-to-consumer (DTC) tests authorized by the FDA that provide information on an individual’s genetic predisposition to certain medical diseases or conditions, which may help to make decisions about l ...
Posted 1 Apr 2011 by Drugs.com
THURSDAY, March 31 – For people with the movement disorder dystonia, starting deep brain stimulation therapy early in the course of the disease provides better results, according to a new study. Dystonia is a potentially crippling disorder that causes muscles to contract, resulting in involuntary twisting of affected areas of the body. Deep brain stimulation is approved in the United States for ...